Department of Vascular Surgery.
Department of Endocrinology.
J Hypertens. 2021 Sep 1;39(9):1918-1925. doi: 10.1097/HJH.0000000000002852.
Adrenal vein sampling (AVS) is recommended for discriminating patients with unilateral primary aldosteronism from bilateral disease. However, it is a technically demanding procedure that is markedly underused. We developed a computed tomography image fusion, coaxial guidewire technique, fast intraprocedural cortisol testing (CCF) technique to improve AVS success rate, which combines CT image fusion, coaxial guidewire technique, and fast intraprocedural cortisol testing.
To evaluate the effectiveness and safety of the AVS--CCF technique.
We retrospectively evaluated 105 patients who undervent AVS from June 2016 to October 2020. There were 51 patients in the AVS--CCF group and 54 patients in the AVS group. We compared two groups with technical success rate, procedure time, radiation exposure, volume of contrast medium, and complications (adrenal vein rupture, dissection, infarction, or thrombosis; intraglandular or periadrenal hematoma; and contrast-induced nephropathy).
The technical success rate was higher for AVS--CCF than for AVS without CCF (98 vs. 83.3% for bilateral adrenal veins, P = 0.016). AVS--CCF was associated with a shorter procedure time (63.6 ± 24.6 vs. 94.8 ± 40.8 min, P < 0.001), shorter fluoroscopy time (15.6 ± 12.6 vs. 20.4 ± 15.0 min, P = 0.043), and lower contrast medium volume (25.10 ± 21.82 vs. 44.1 ± 31.0 ml, P < 0.001). There were no significant differences between groups with respect to the time for cannulating the left or right adrenal vein or the peak skin radiation dose. Adrenal vein rupture occurred in 14 patients and intraglandular hematoma in 1 patient.
The CCF technique during AVS not only contributed to improved technical success rates but also associated with decreased procedure time, radiation exposure, and contrast medium volume.
肾上腺静脉采样(AVS)被推荐用于区分单侧原发性醛固酮增多症与双侧疾病。然而,它是一项技术要求很高的操作,目前的应用明显不足。我们开发了一种计算机断层扫描图像融合同轴导丝技术,快速术中皮质醇检测(CCF)技术,以提高 AVS 的成功率,该技术结合了 CT 图像融合、同轴导丝技术和快速术中皮质醇检测。
评估 AVS-CCF 技术的有效性和安全性。
我们回顾性评估了 2016 年 6 月至 2020 年 10 月期间接受 AVS 的 105 例患者。其中 AVS-CCF 组 51 例,AVS 组 54 例。我们比较了两组的技术成功率、手术时间、辐射暴露、造影剂用量和并发症(肾上腺静脉破裂、夹层、梗死或血栓形成;肾上腺内或肾上腺周围血肿;对比剂肾病)。
AVS-CCF 的技术成功率高于无 CCF 的 AVS(双侧肾上腺静脉为 98%比 83.3%,P=0.016)。AVS-CCF 与手术时间更短(63.6±24.6 比 94.8±40.8 分钟,P<0.001)、透视时间更短(15.6±12.6 比 20.4±15.0 分钟,P=0.043)和造影剂用量更少(25.10±21.82 比 44.1±31.0 毫升,P<0.001)有关。两组在左或右肾上腺静脉穿刺时间或皮肤最大辐射剂量方面无显著差异。肾上腺静脉破裂 14 例,肾上腺内血肿 1 例。
AVS 期间的 CCF 技术不仅有助于提高技术成功率,而且与手术时间缩短、辐射暴露减少和造影剂用量减少有关。